Evidence map›Paper›PMID 34997317›Full record

ArticleCellular and molecular life sciences : CMLS2022

SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.

Wenwen Zhang, Shuofei Yang, Datian Chen, Daolu Yuwen, Juan Zhang, Xiaowei Wei, Xin Han, Xiaoxiang Guan

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Wenwen Zhang *Department of Oncology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China. wwzhang1022@hotmail.com.ORCID http://orcid.org/0000-0003-1285-3118
Shuofei Yang *Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Datian Chen *Department of Oncology, Haimen People's Hospital, Nantong University, Nantong, China.
Daolu YuwenDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
Juan ZhangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
Xiaowei WeiDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
Xin HanJiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. xhan0220@njucm.edu.cn.
Xiaoxiang GuanDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China. xguan@njmu.edu.cn.
Nanjing Medical University · CNJiangsu Cancer Hospital · CNNanjing University of Chinese Medicine · CNNantong University · CNRenji Hospital · CN

Funding

Key Foundation for Social Development Project of the Jiangsu Province, China BE2021741Key International Cooperation of the National Natural Science Foundation of China 81920108029Nanjing Outstanding Youth Fund JQX20009National Natural Science Foundation of China 81773102National Natural Science Foundation of China 81802667Natural Science Foundation of Jiangsu Province BK20180133
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) has an aggressive biological behavior and poor outcome. Our published study showed that PAI-1 could induce the migration and metastasis of TNBC cells. However, the underlying mechanism by which PAI-1 regulates TNBC metastasis has not been addressed. Here, we demonstrated that PAI-1 is high expressed in TNBC and promotes TNBC cells tumorigenesis. Using microarray analysis of lncRNA expression profiles, we identified a lncRNA SOX2-OT, which is induced by PAI-1 and could function as an oncogenic lncRNA in TNBC. Mechanistic analysis demonstrated that SOX2-OT acts as a molecular sponge for miR-942-5p to regulate the expression of PIK3CA, ultimately leading to activating PI3K/Akt signaling pathway and promoting TNBC metastasis. Taken together, our findings suggest that SOX2-OT regulates PAI-1-induced TNBC cell metastasis through miR-942-5p/PIK3CA signaling and illustrate the great potential of developing new SOX2-OT-targeting therapy for TNBC patients.

Indexed as

Cell Line, TumorCell Transformation, NeoplasticClass I Phosphatidylinositol 3-KinasesGene Expression Regulation, NeoplasticHumansMicroRNAsNeoplasm MetastasisPlasminogen Activator Inhibitor 1Proto-Oncogene Proteins c-aktRNA, Long NoncodingSignal TransductionTriple Negative Breast NeoplasmsClass I Phosphatidylinositol 3-Kinaseslong non-coding RNA Sox2ot, humanMicroRNAsMIRN942 microRNA, humanPIK3CA protein, humanPlasminogen Activator Inhibitor 1Proto-Oncogene Proteins c-aktRNA, Long NoncodingSERPINE1 protein, humanceRNALung and liver metastasesLY294002PAI-039PAI-1/SERPINE1

Identifiers

PMID34997317
PMCPMC11072091
OpenAlexW4205257525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.